Central role of mitochondria in drug-induced liver injury
Abstract
A frequent mechanism for drug-induced liver injury (DILI) is the formation of reactive metabolites that trigger hepatitis through direct toxicity or immune reactions. Both events cause mitochondrial membrane disruption. Genetic or acquired factors predispose to metabolite-mediated hepatitis by increasing the formation of the reactive metabolite, decreasing its detoxification, or by the presence of critical human leukocyte antigen molecule(s). In other instances, the parent drug itself triggers mitochondrial membrane disruption or inhibits mitochondrial function through different mechanisms. Drugs can sequester coenzyme A or can inhibit mitochondrial β-oxidation enzymes, the transfer of electrons along the respiratory chain, or adenosine triphosphate (ATP) synthase. Drugs can also destroy mitochondrial DNA, inhibit its replication, decrease mitochondrial transcripts, or hamper mitochondrial protein synthesis. Quite often, a single drug has many different effects on mitochondrial function. A severe impairment of oxidative phosphorylation decreases hepatic ATP, leading to cell dysfunction or necrosis; it can also secondarily inhibit ß-oxidation, thus causing steatosis, and can also inhibit pyruvate catabolism, leading to lactic acidosis. A severe impairment of β-oxidation can cause a fatty liver; further, decreased gluconeogenesis and increased utilization of glucose to compensate for the inability to oxidize fatty acids, together with the mitochondrial toxicity of accumulated free fatty acids and lipid peroxidation products, may impair energy production, possibly leading to coma and death. Susceptibility to parent drug-mediated mitochondrial dysfunction can be increased by factors impairing the removal of the toxic parent compound or by the presence of other medical condition(s) impairing mitochondrial function. New drug molecules should be screened for possible mitochondrial effects.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Chronic and/or binge alcohol, high fat diets, tobacco smoking, or certain hepatotoxic drugs can directly damage the mitochondrial ETC, producing greater amounts of ROS leaked from the ETS.
“However, chronic and/or binge alcohol, high fat diets, tobacco smoking, or certain hepatotoxic drugs can directly damage the mitochondrial ETC, producing greater amounts of ROS leaked from the ETS [24], [25], [26], [27].”
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672 · see citing works
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,197 · see citing works
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084 · see citing works
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445 · see citing works
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · see citing works
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · see citing works
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317 · see citing works
Urano, F., Wang, X.-Z., Bertolotti, A., Zhang, Y., Chung, P., Harding, H. P., & Ron, D. (2000) · Science · doi:10.1126/science.287.5453.664 · Cited by 2,997 · see citing works
Roles of CHOP/GADD153 in endoplasmic reticulum stress
Oyadomari, S., & Mori, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401373 · Cited by 2,833 · see citing works
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · cited 1× · see citing works
“Genetic differences in CYP expression CYP isoenzymes are under genetic control, and hepatic levels of a given isoenzyme differ considerably in different people (Shimada et al., 1994).”
BackgroundAntiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · see citing works
Physiological functions of thioredoxin and thioredoxin reductase
Arnér, E. S. J., & Holmgren, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01701.x · Cited by 2,535 · see citing works
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233 · see citing works
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078 · see citing works
Mitochondria, oxidative stress and cell death
Ott, M., Gogvadze, V. G., Orrenius, S., & Zhivotovsky, B. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0756-2 · Cited by 1,976 · see citing works
Leist, M., Single, B., Castoldi, A. F., Kühnle, S., & Nicotera, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1481 · Cited by 1,871 · see citing works
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29666-5 · Cited by 1,737 · see citing works
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Cantó, C., & Auwerx, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328328d0a4 · Cited by 1,624 · see citing works
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M. P., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,601 · see citing works
Germain, R. N. (1994) · Cell · doi:10.1016/0092-8674(94)90336-0 · Cited by 1,431 · see citing works
Fridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401 · see citing works
Desagher, S., Osen‐Sand, A., Nichols, A. C., Eskes, R., Montessuit, S., Lauper, S., Maundrell, K., Antonsson, B. E., & Martinou, J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.5.891 · Cited by 1,260 · see citing works
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El‐Serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,232 · see citing works
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO
Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., & Brodie, B. B. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29664-1 · Cited by 1,203 · see citing works
The apoptosome: Signalling platform of cell death
Riedl, S. J., & Salvesen, G. S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2153 · Cited by 1,097 · see citing works
Acetaminophen-Induced Hepatic Necrosis
Jollow, D. J., Thorgeirsson, S. S., Potter, W. Z., Hashimoto, M., & Mitchell, J. R. (2008) · Pharmacology · doi:10.1159/000136547 · Cited by 1,091 · see citing works
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085 · see citing works
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
study, F. T. D., Daly, A. K., Donaldson, P. T., Bhatnagar, P., Shen, Y., Pe’er, I., Floratos, A., Daly, M. J., Goldstein, D. B., John, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.379 · Cited by 1,041 · see citing works
Mitsuya, H., & Broder, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1911 · Cited by 1,041 · see citing works
Molecular mechanisms of quinone cytotoxicity
O'Brien, P. J. (1991) · Chemico-Biological Interactions · doi:10.1016/0009-2797(91)90029-7 · Cited by 1,031 · see citing works
Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., & Leonard, E. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9233 · Cited by 984 · see citing works
Mitochondrial permeability transition and oxidative stress
Kowaltowski, A. J., Castilho, R. F., & Vercesi, A. E. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02316-x · Cited by 832 · see citing works
Mitochondria as regulators of apoptosis: doubt no more
Susín, S. A., Zamzami, N., & Kroemer, G. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00110-8 · Cited by 830 · see citing works
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829 · see citing works
Antigen-presenting cell function in the tolerogenic liver environment
Thomson, A. W., & Knolle, P. A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2858 · Cited by 804 · see citing works
Mitochondrial toxicity of antiviral drugs
Lewis, W., & Dalakas, M. C. (1995) · Nature Medicine · doi:10.1038/nm0595-417 · Cited by 766 · see citing works
Cai, J., & Jones, D. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11401 · Cited by 765 · see citing works
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Leclercq, I. A., Farrell, G. C., Field, J., Bell, D., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 763 · see citing works
Regulation of apoptosis by endoplasmic reticulum pathways
Breckenridge, D. G., Germain, M., Mathai, J. P., Nguyen, M., & Shore, G. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207108 · Cited by 742 · see citing works
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734 · see citing works
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 692 · see citing works
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., & Runkel, L. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.5.1223 · Cited by 692 · see citing works
Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
Shear, N. H., & Spielberg, S. P. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113798 · Cited by 687 · see citing works
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
Fromenty, B., & Pessayre, D. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00012-6 · Cited by 665 · see citing works
Self-citationMitochondrial disease in mouse results in increased oxidative stress
Esposito, L., Melov, S., Panov, A. V., Cottrell, B. A., & Wallace, D. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4820 · Cited by 637 · see citing works
Boehning, D. F., Patterson, R. L., Sedaghat, L., Glebova, N. O., Kurosaki, T., & Snyder, S. H. (2003) · Nature Cell Biology · doi:10.1038/ncb1063 · Cited by 636 · see citing works
Peroxynitrite reactions and formation in mitochondria
Radí, R., Cassina, A., Hodara, R., Quijano, C., & Castro, L. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01111-5 · Cited by 635 · see citing works
Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily
Watkins, P. B., Kaplowitz, N., Slattery, J. T., Colonese, C. R., Colucci, S. V., Stewart, P. W., & Harris, S. (2006) · JAMA · doi:10.1001/jama.296.1.87 · Cited by 631 · see citing works
McKenzie, R., Fried, M. W., Sallie, R., Conjeevaram, H., Di Bisceglie, A. M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., Luciano, C., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510263331702 · Cited by 616 · see citing works
Implication of free radical mechanisms in ethanol-induced cellular injury
Nordmann, R., Ribière, C., & Rouach, H. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90030-k · Cited by 610 · see citing works
Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis
Zong, W., Li, C., Hatzivassiliou, G., Lindsten, T., Yu, Q., Yuan, J., & Thompson, C. B. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302084 · Cited by 595 · see citing works
Deniaud, A., Sharaf el dein, O., Maillier, E., Poncet, D., Kroemer, G., Lemaire, C., & Brenner, C. (2008) · Oncogene · doi:10.1038/sj.onc.1210638 · Cited by 586 · see citing works
Dinkova‐Kostova, A. T., Liby, K. T., Stephenson, K. K., Holtzclaw, W. D., Gao, X., Suh, N., Williams, C. R., Risingsong, R., Honda, T., Gribble, G. W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500815102 · Cited by 575 · see citing works
Begriche, K., Massart, J., Robin, M., Borgne‐Sanchez, A., & Fromenty, B. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.006 · Cited by 553 · see citing works
Self-citationYou, M., Fischer, M., Deeg, M. A., & Crabb, D. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202411200 · Cited by 543 · see citing works
Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling
Cox, A. G., Winterbourn, C. C., & Hampton, M. B. (2009) · Biochemical Journal · doi:10.1042/bj20091541 · Cited by 530 · see citing works
Reactive oxygen species and antioxidant vitamins: Mechanisms of action
Frei, B. B. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90292-5 · Cited by 529 · see citing works
Hanawa, N., Shinohara, M., Saberi, B., Gaarde, W. A., Han, D., & Kaplowitz, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708916200 · Cited by 527 · see citing works
Sulkowski, M., Thomas, D. L., Mehta, S. H., Chaisson, R. E., & Moore, R. D. (2002) · Hepatology · doi:10.1053/jhep.2002.30319 · Cited by 523 · see citing works
Costantini, P., Chernyak, B. V., Petronilli, V., & Bernardi, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6746 · Cited by 516 · see citing works
Tumor Cell Death Induced by Topoisomerase-Targeting Drugs
Li, T., & Liu, L. F. (2001) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.53 · Cited by 509 · see citing works
Mitochondrial abnormalities in non-alcoholic steatohepatitis
Caldwell, S. H., Swerdlow, R. H., Khan, E. M., Iezzoni, J. C., Hespenheide, E. E., Parks, J. K., & Parker, W. D. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80033-6 · Cited by 495 · see citing works
A Fetal Fatty-Acid Oxidation Disorder as a Cause of Liver Disease in Pregnant Women
Ibdah, J. A., Bennett, M. J., Rinaldo, P., Zhao, Y., Gibson, B., Sims, H. F., & Strauss, A. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402204 · Cited by 489 · see citing works
Toll–Like Receptor 4 Is Involved in the Mechanism of Early Alcohol–Induced Liver Injury in Mice
Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., & Thurman, R. G. (2001) · Hepatology · doi:10.1053/jhep.2001.25350 · Cited by 488 · see citing works
Alterations in Liver ATP Homeostasis in Human Nonalcoholic Steatohepatitis
Cortez‐Pinto, H., Chatham, J. C., Chacko, V. P., Arnold, C., Rashid, A., & Diehl, A. M. (1999) · JAMA · doi:10.1001/jama.282.17.1659 · Cited by 487 · see citing works
Lysosomal Membrane Permeabilization Induces Cell Death in a Mitochondrion-dependent Fashion
Boya, P., Andreau, K., Poncet, D., Zamzami, N., Perfettini, J.-L., Metivier, D., Ojcius, D. M., Jäättelä, M., & Kroemer, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021952 · Cited by 483 · see citing works
Bax and Bak Coalesce into Novel Mitochondria-Associated Clusters during Apoptosis
Nechushtan, A., Smith, C. L., Lamensdorf, I., Yoon, S., & Youle, R. J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.6.1265 · Cited by 477 · see citing works
Lucena, M. I., Molokhia, M., Shen, Y., Urban, T. J., Aithal, G. P., Andrade, R. J., Day, C. P., Ruiz‐Cabello, F., Donaldson, P. T., Stephens, C. M., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.001 · Cited by 474 · see citing works
C-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity
Gunawan, B. K., Liu, Z., Han, D., Hanawa, N., Gaarde, W. A., & Kaplowitz, N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.045 · Cited by 471 · see citing works
Transcription-independent pro-apoptotic functions of p53
Moll, U. M., Wolff, S., Speidel, D., & Deppert, W. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.007 · Cited by 468 · see citing works
Side effects of high-dose interferon therapy for chronic hepatitis C
Okanoue, T., Sakamoto, S., Itoh, Y., Minami, M., Yasui, K., Sakamoto, M., Nishioji, K., Katagishi, T., Nakagawa, Y., Tada, H., et al. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80113-9 · Cited by 456 · see citing works
Pessayre, D., & Fromenty, B. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.004 · Cited by 441 · see citing works
Self-citationHuang, Y., Chern, H., Su, W., Wu, J., Lai, S., Yang, S., Chang, F., & Lee, S. (2002) · Hepatology · doi:10.1053/jhep.2002.32102 · Cited by 437 · see citing works
Human Fas ligand: gene structure, chromosomal location and species specificity
Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T., & Nagata, S. (1994) · International Immunology · doi:10.1093/intimm/6.10.1567 · Cited by 433 · see citing works
Korenaga, M., Wang, T., Li, Y., Showalter, L., Chan, T., Sun, J., & Weinman, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506412200 · Cited by 426 · see citing works
Cytochrome P450 2E1 Genotype and the Susceptibility to Antituberculosis Drug–Induced Hepatitis
Huang, Y., Chern, H., Su, W., Wu, J., Chang, S.-C., Chiang, C., Chang, F., & Lee, S. (2003) · Hepatology · doi:10.1053/jhep.2003.50144 · Cited by 425 · see citing works
Acetaminophen Hepatotoxicity in Alcoholics: A Therapeutic Misadventure
SEEFF, L. B., CUCCHERINI, B. A., ZIMMERMAN, H. J., ADLER, E., & BENJAMIN, S. B. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-399 · Cited by 424 · see citing works
Mitochondrial DNA Mutations and Pathogenesis
Schon, E. A., Bonilla, E., & DiMauro, S. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022685929755 · Cited by 421 · see citing works
Anticonvulsant Hypersensitivity Syndrome
Vittorio, C. C. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430210033005 · Cited by 421 · see citing works
Berhane, K., Widersten, M., Engström, Å., Kozarich, J. W., & Mannervik, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1480 · Cited by 414 · see citing works
Berson, A., de Beco, V., Lettéron, P., Robin, M. A., Moreau, C., Elkahwaji, J. E., Verthier, N., Feldmann, G., Fromenty, B., & Pessayre, D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70590-6 · Cited by 402 · see citing works
Self-citationToxicity of Antiviral Nucleoside Analogs and the Human Mitochondrial DNA Polymerase
Johnson, A. A., Ray, A. S., Hanes, J. W., Suo, Z., Colacino, J. M., Anderson, K. S., & Johnson, K. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106743200 · Cited by 399 · see citing works
Valproate–Induced Hepatic Injury: Analyses of 23 Fatal Cases
Zimmerman, H. J., & Ishak, K. G. (1982) · Hepatology · doi:10.1002/hep.1840020513 · Cited by 394 · see citing works
Impaired fatty acid oxidation in propofol infusion syndrome
WOLF, A. R., Weir, P., Segar, P., Stone, J., & Hamilton-Shield, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04064-2 · Cited by 392 · see citing works
Sutton, A., Khoury, H., Prip‐Buus, C., Cepanec, C., Pessayre, D., & Degoul, F. (2003) · PubMed · doi:10.1097/01.fpc.0000054067.64000.8f · Cited by 389 · see citing works
Self-citationLammert, C. S., Einarsson, S., Saha, C., Niklasson, A., Bjornsson, E. S., & Chalasani, N. (2008) · Hepatology · doi:10.1002/hep.22272 · Cited by 389 · see citing works
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
Singer, J. B., Lewitzky, S., Leroy, E., Yang, F., Zhao, X., Klickstein, L. B., Wright, T. M., Meyer, J. M., & Paulding, C. (2010) · Nature Genetics · doi:10.1038/ng.632 · Cited by 386 · see citing works
Majamaa, K., Moilanen, J. S., Uimonen, S., Remes, A. M., Salmela, P. I., Kärppä, M., Majamaa‐Voltti, K., Rusanen, H., Sorri, M., PEUHKURINEN, K. J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301959 · Cited by 385 · see citing works
Boya, P., Gonzalez-Polo, R.-A., Poncet, D., Andreau, K., Vieira, H. L., Roumier, T., Perfettini, J.-L., & Kroemer, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206622 · Cited by 385 · see citing works
The Role of Keap1 in Cellular Protective Responses
Dinkova‐Kostova, A. T., Holtzclaw, W. D., & Kensler, T. W. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050217c · Cited by 378 · see citing works
Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity
SHEAR, N. H., SPIELBERG, S. P., GRANT, D. M., TANG, B. K., & KALOW, W. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-179 · Cited by 373 · see citing works
Cover, C., Mansouri, A., Knight, T. R., Bajt, M. L., Lemasters, J. J., Pessayre, D., & Jaeschke, H. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088898 · Cited by 373 · see citing works
Self-citationIsoniazid-Associated Hepatitis in 114 Patients
Black, M., Mitchell, J. R., Zimmerman, H. J., Ishak, K. G., & Epler, G. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32568-5 · Cited by 370 · see citing works
Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid
Fulda, S., Scaffidi, C., Susín, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., & Debatin, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33942 · Cited by 370 · see citing works
Kindmark, A., Jawaid, A., Harbron, C. G., Barratt, B. J., Bengtsson, O., Andersson, T. B., Carlsson, S., Cederbrant, K., Gibson, N. J., Armstrong, M., et al. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500458 · Cited by 367 · see citing works
Erster, S. H., Mihara, M., Kim, R. H., Petrenko, O., & Moll, U. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6728-6741.2004 · Cited by 367 · see citing works
Chloramphenicol in the Newborn Infant
Weiss, C. F., Glazko, A. J., & Weston, J. K. (1960) · New England Journal of Medicine · doi:10.1056/nejm196004212621601 · Cited by 354 · see citing works
Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides
Oates, J. A., Wood, A. J. J., Yarchoan, R., Mitsuya, H., Myers, C. E., & Broder, S. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909143211106 · Cited by 353 · see citing works
Enzymatic activation of chemicals to toxic metabolites
Guengerich, F. P., Liebler, D. C., & Reed, D. L. (1985) · Critical Reviews in Toxicology · doi:10.3109/10408448509037460 · Cited by 335 · see citing works
Recognition and management of fatty acid oxidation defects: A series of 107 patients
Saudubray, J., Martin, D., de Lonlay, P., Touati, G., Poggi-Travert, F., Bonnet, D., Jouvet, P. A., Boutron, M. C., Slama, A., Vianey‐Saban, C., et al. (1999) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005556207210 · Cited by 330 · see citing works
Linezolid-Induced Inhibition of Mitochondrial Protein Synthesis
Vriese, A. S. D., Coster, R. V., Smet, J., Seneca, S., Lovering, A. M., Haute, L. V., Vanopdenbosch, L. J., Martin, J., Groote, C. C., Vandecasteele, S. J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/501356 · Cited by 325 · see citing works
Beaune, P. H., Dansette, P. M., Mansuy, D., Kiffel, L., Finck, M., Amar, C., Leroux, J. P., & Homberg, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.551 · Cited by 319 · see citing works
Rahmani, Z., Huh, K.-W., Lasher, R. S., & Siddiqui, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2840-2846.2000 · Cited by 319 · see citing works
Martin, A. M., Nolan, D. A., JAMES, I. R., Cameron, P. U., Keller, J., Moore, C., Phillips, E. J., Christiansen, F., & Mallal, S. A. (2004) · AIDS · doi:10.1097/00002030-200501030-00014 · Cited by 317 · see citing works
Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice
Masubuchi, Y., Suda, C., & Horie, T. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.015 · Cited by 317 · see citing works
Wit, F. W. N. M., Weverling, G. J., Weel, J. F. L., Jurriaans, S., & Lange, J. M. A. (2002) · The Journal of Infectious Diseases · doi:10.1086/341084 · Cited by 314 · see citing works
Kassahun, K., Pearson, P. G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Wang, R., Doss, G., & Baillie, T. A. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000180q · Cited by 311 · see citing works
Granzyme B–Mediated Cytochrome C Release Is Regulated by the Bcl-2 Family Members Bid and Bax
Heibein, J. A., Goping, I. S., Barry, M., Pinkoski, M. J., Shore, G. C., Green, D. R., & Bleackley, R. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1391 · Cited by 311 · see citing works
Reid, A. B., Kurten, R. C., McCullough, S. S., Brock, R. W., & Hinson, J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075945 · Cited by 302 · see citing works
Polavarapu, R., Spitz, D. R., Sim, J. E., Follansbee, M. H., Oberley, L. W., Rahemtulla, A., & Nanji, A. A. (1998) · Hepatology · doi:10.1002/hep.510270518 · Cited by 301 · see citing works
Ungo, J., Jones, D., Ashkin, D., Hollender, E. S., Bernstein, D. E., Albanese, A., & Pitchenik, A. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9711039 · Cited by 292 · see citing works
HLA association of amoxicillin-clavulanate–induced hepatitis
Hautekèete, M., Horsmans, Y., Waeyenberge, C. V., Demanet, C. J., Henrion, J., Verbist, L., Brenard, R., Sempoux, C. L., Michielsen, P. P., Yap, P. S. H., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70404-x · Cited by 285 · see citing works
Vergani, D., Mieli‐Vergani, G., Alberti, A., Neuberger, J., Eddleston, A. L. W. F., Davis, M. R., & Williams, R. L. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007103030202 · Cited by 284 · see citing works
Metabolic Activation of Drugs to Toxic Substances
Mitchell, J. R., & Jollows, D. J. (1975) · Gastroenterology · doi:10.1016/s0016-5085(75)80025-4 · Cited by 279 · see citing works
Chen, C. H., & Cheng, Y. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80156-9 · Cited by 278 · see citing works
Hepatotoxicity due to mitochondrial dysfunction
Pessayre, D., Mansouri, A., Haouzi, D., & Fromenty, B. (1999) · Cell Biology and Toxicology · doi:10.1023/a:1007649815992 · Cited by 274 · see citing works
Self-citationSpraggs, C. F., Budde, L. R., Briley, L. P., Bing, N., Cox, C. J., King, K. S., Whittaker, J. C., Mooser, V., Preston, A. J., Stein, S. H., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3197 · Cited by 274 · see citing works
Mitochondrial Disease: A Practical Approach for Primary Care Physicians
Haas, R., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darín, N., & Cohen, B. H. (2007) · PEDIATRICS · doi:10.1542/peds.2007-0391 · Cited by 272 · see citing works
Lysosomes as “Suicide Bags” in Cell Death: Myth or Reality?
Turk, B., & Türk, V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.023820 · Cited by 270 · see citing works
Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis
Natori, S., Rust, C., Stadheim, L. M., Srinivasan, A. N., Burgart, L. J., & Gores, G. J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00089-1 · Cited by 268 · see citing works
Leonarduzzi, G., Scavazza, A., Biasi, F., Chiarpotto, E., Camandola, S., Vogl, S., Dargel, R., & Poli, G. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.11.9285483 · Cited by 264 · see citing works
Chalasani, N. (2005) · Hepatology · doi:10.1002/hep.20671 · Cited by 264 · see citing works
Co-amoxiclav jaundice: clinical and histological features and HLA class II association
O’Donohue, J., Oien, K. A., Donaldson, P., Underhill, J., Clare, M., MacSween, R. N. M., & Mills, P. R. (2000) · Gut · doi:10.1136/gut.47.5.717 · Cited by 261 · see citing works
Chariot, P., Drogou, I., de Lacroix-Szmania, I., Eliezer‐Vanerot, M., Chazaud, B., Lombès, A., Schaeffer, A., & Zafrani, É. S. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80020-8 · Cited by 259 · see citing works
Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes
Laine, J., Auriola, S. O. K., Pasanen, M., & Juvonen, R. O. (2009) · Xenobiotica · doi:10.1080/00498250802512830 · Cited by 258 · see citing works
Tsutsumi, S., Gotoh, T., Tomisato, W., Mima, S., Hoshino, T., Hwang, H.-J., Takenaka, H., Tsuchiya, T., Mori, M., & Mizushima, T. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401436 · Cited by 255 · see citing works
Nakagawa, H., Maeda, S., Hikiba, Y., Ohmae, T., Shibata, W., Yanai, A., Sakamoto, K., Ogura, K., Noguchi, T., Karin, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.006 · Cited by 253 · see citing works
Oral Medications With Significant Hepatic Metabolism at Higher Risk for Hepatic Adverse Events
Lammert, C. S., Bjornsson, E. S., Niklasson, A., & Chalasani, N. (2009) · Hepatology · doi:10.1002/hep.23317 · Cited by 251 · see citing works
Altered Thiol and Calcium Homeostasis in Oxidative Hepatocellular Injury
Bellomo, G., & Orrenius, S. (1985) · Hepatology · doi:10.1002/hep.1840050529 · Cited by 249 · see citing works
Bédossa, P., Houglum, K., Trautwein, C., Holstege, A., & Chojkier, M. (1994) · Hepatology · doi:10.1002/hep.1840190527 · Cited by 248 · see citing works
A polymorphism in the CYP17 gene increases the risk of breast cancer.
Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K., & Henderson, B. E. (1997) · PubMed · Cited by 247 · see citing works
Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins
Chipuk, J. E., Fisher, J. C., Dillon, C. P., Kriwacki, R. W., Kuwana, T., & Green, D. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808036105 · Cited by 246 · see citing works
Borutaitė, V., & Brown, G. C. (1996) · Biochemical Journal · doi:10.1042/bj3150295 · Cited by 243 · see citing works
Fernández-Checa, J. C., García‐Ruiz, C., Ookhtens, M., & Kaplowitz, N. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115010 · Cited by 242 · see citing works
Polymerase γ Gene POLG Determines the Risk of Sodium Valproate-Induced Liver Toxicity
Stewart, J. D., Horváth, R., Baruffini, E., Ferrero, I., Bulst, S., Watkins, P. B., Fontana, R. J., Day, C. P., & Chinnery, P. F. (2010) · Hepatology · doi:10.1002/hep.23891 · Cited by 242 · see citing works
Feigelson, H. S., Shames, L. S., Pike, M. C., Coetzee, G. A., Stanczyk, F. Z., & Henderson, B. E. (1998) · PubMed · Cited by 241 · see citing works
Dai, Y., Rashba-Step, J., & Cederbaum, A. I. (1993) · Biochemistry · doi:10.1021/bi00078a017 · Cited by 240 · see citing works
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
Jedlitschky, G., Hoffmann, U., & Kroemer, H. K. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.3.351 · Cited by 239 · see citing works
Bartlett, J. G. (1998) · PubMed · Cited by 238 · see citing works
Bruno, S., Maisonneuve, P., Castellana, P., Rotmensz, N., Rossi, S., Maggioni, M., Persico, M., Colombo, A. E., Monasterolo, F., Giunchi, D. C., et al. (2005) · BMJ · doi:10.1136/bmj.38391.663287.e0 · Cited by 233 · see citing works
Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection
Wong, W., Wu, P., Yuen, M., Cheng, C.-C., Yew, W.-W., Wong, P.-C., Tam, C. M., Leung, C., & Lai, C. (2000) · Hepatology · doi:10.1002/hep.510310129 · Cited by 231 · see citing works
Mansouri, A., Demeilliers, C., Amsellem, S., Pessayre, D., & Fromenty, B. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29435-0 · Cited by 228 · see citing works
Self-citationWu, J., Wong, W. W.-L., Khosravi, F., Minden, M. D., & Penn, L. Z. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0866 · Cited by 225 · see citing works
Chitturi, S., & Farrell, G. C. (2000) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-000-0034-7 · Cited by 221 · see citing works
Dykens, J. A., Jamieson, J., Marroquin, L., Nadanaciva, S., Billis, P. A., & Will, Y. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.08.013 · Cited by 220 · cited 1× · see citing works
“At such high intramitochondrial concentrations, phenformin becomes a potent inhibitor of oxygen consumption, ATP formation, and cell survival in HepG2 cells grown on galactose (Dykens et al., 2008a).”
BackgroundAithal, G. P., Ramsay, L., Daly, A. K., Sonchit, N., Leathart, J. B. S., Alexander, G., Kenna, J. G., Caldwell, J., & Day, C. P. (2004) · Hepatology · doi:10.1002/hep.20205 · Cited by 216 · see citing works
Adaptation to Oxidative Stress, Chemoresistance, and Cell Survival
Landriscina, M., Maddalena, F., Laudiero, G., & Esposito, F. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2692 · Cited by 215 · see citing works
Human mitochondrial topoisomerase I
Zhang, H., Barceló, J. M., Lee, B., Kohlhagen, G., Zimonjic, D. B., Popescu, N. C., & Pommier, Y. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191321998 · Cited by 215 · see citing works
Huang, Y., Su, W., Huang, Y., Chen, C., Chang, F.-Y., Lin, H., & Lee, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.009 · Cited by 212 · see citing works
Ravagnan, L., Marzo, I., Costantini, P., Susín, S. A., Zamzami, N., PETIT, P. X., Hirsch, F., Goulbern, M., Poupon, M., Miccoli, L., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202625 · Cited by 210 · see citing works
An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice
Mansouri, A., Gaou, I., de Kerguenec, C., Amsellem, S., Haouzi, D., Berson, A., Moreau, A., Feldmann, G., Lettéron, P., Pessayre, D., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70566-4 · Cited by 208 · see citing works
Self-citationKenna, J. G., Satoh, H., Christ, D. D., & Pohl, L. R. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24104-0 · Cited by 208 · see citing works
Bourdi, M., Larrey, D. G., Nataf, J., Bernuau, J., Pessayre, D., Iwasaki, M., Guengerich, F. P., & Beaune, P. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114660 · Cited by 206 · see citing works
Self-citationBröker, L. E., Huisman, C., Span, S. W., Rodríguez, J. A., Kruyt, F. A. E., & Giaccone, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3060 · Cited by 206 · see citing works
Textbook of hepatology : from basic science to clinical practice
Rodés, J. (2007) · Cited by 200 · see citing works
Fagian, M. M., Pereira-da-Silva, L., Martins, I. S., & Vercesi, A. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45467-6 · Cited by 198 · see citing works
Cationic amphiphilic drugs and phospholipid storage disorder.
Kodavanti, U. P., & Mehendale, H. M. (1990) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00049-3 · Cited by 197 · see citing works
Dykens, J. A., Jamieson, J. D., Marroquin, L. D., Nadanaciva, S., Xu, J. J., Dunn, M. C., Smith, A. R., & Will, Y. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn056 · Cited by 195 · see citing works
Belzacq, A.-S., Hamel, C. E., Vieira, H. L. A., Cohen, I., Haouzi, D., Métivier, D., Marchetti, P., Brenner, C., & Kroemer, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204953 · Cited by 194 · see citing works
Lucena, M. I., Andrade, R. J., Martínez, C., Ulzurrun, E., García‐Martín, E., Borraz, Y., Fernández, M. C., Romero‐Gómez, M., Castiella, A., Planas, R., et al. (2008) · Hepatology · doi:10.1002/hep.22370 · Cited by 194 · see citing works
DNA Topoisomerases as Anticancer Drug Targets
Schneider, E., Hsiang, Y. H., & Liu, L. F. (1990) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60342-7 · Cited by 193 · see citing works
Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax
Fletcher, J. I., Meusburger, S., Hawkins, C. J., Riglar, D. T., Lee, E. F., Fairlie, W. D., Huang, D. C. S., & Adams, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808691105 · Cited by 193 · see citing works
Lettéron, P., Sutton, A., Mansouri, A., Fromenty, B., & Pessayre, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50309 · Cited by 189 · see citing works
Self-citationHuman Cytochrome P450 2E1 Is a Major Autoantigen Associated with Halothane Hepatitis
Bourdi, M., Chen, W., Peter, R. M., Martin, J. L., Buters, J., Nelson, S. D., & Pohl, L. R. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960083q · Cited by 189 · see citing works
Role of CHOP in Hepatic Apoptosis in the Murine Model of Intragastric Ethanol Feeding
Ji, C., Mehrian‐Shai, R., Chan, C., Hsu, Y., & Kaplowitz, N. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000174691.03751.11 · Cited by 189 · see citing works
Mechanisms of benzarone and benzbromarone‐induced hepatic toxicity†
Kaufmann, P., Török, M., Hänni, A., Roberts, P. A., Gasser, R., & Krähenbühl, S. (2005) · Hepatology · doi:10.1002/hep.20634 · Cited by 187 · see citing works
de la Asunción, J. G., del Olmo, M. L., Sastre, J., Millan, A., Pellı́n, A., Pallardó, F. V., & Viña, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1418 · Cited by 186 · see citing works
Synthetic polyamine analogs as antineoplastics
Bergeron, R. J., Neims, A. H., McManis, J. S., Hawthorne, T. R., Vinson, J. R. T., Bortell, R., & Ingeno, M. J. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00401a019 · Cited by 186 · see citing works
Hirata, K., Takagi, H., Yamamoto, M., Matsumoto, T., Nishiya, T., Mori, K., Shimizu, S., Masumoto, H., & Okutani, Y. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500442 · Cited by 184 · see citing works
HIV-associated lipodystrophy: from fat injury to premature aging
Caron, M., Lagathu, C., Boccara, F., Vigouroux, C., & Capeau, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.002 · Cited by 184 · see citing works
Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats
Masubuchi, Y., Nakayama, S., & Horie, T. (2002) · Hepatology · doi:10.1053/jhep.2002.31871 · Cited by 184 · see citing works
Effects of Aspirin and Acetaminophen on the Liver
Zimmerman, H. J. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.3.333 · Cited by 180 · see citing works
Emery, M. G., Fisher, J. M., Chien, J. Y., Kharasch, E. D., Dellinger, P. E., Kowdley, K. V., & Thummel, K. E. (2003) · Hepatology · doi:10.1053/jhep.2003.50342 · Cited by 179 · see citing works
Clarke, L., & Waxman, D. J. (1989) · PubMed · Cited by 179 · see citing works
Public Health Service Study on Reye’s Syndrome and Medications
Hurwitz, E. S., Barrett, M. J., Bregman, D. J., Gunn, W. J., Schonberger, L. B., Fairweather, W. R., Drage, J. S., Montagne, J. R. L., Kaslow, R. A., Burlington, D. B., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131403 · Cited by 178 · see citing works
Fromenty, B., Fisch, C., Labbe, G., Degott, C., Deschamps, D., Berson, A., Lettéron, P., & Pessayre, D. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22984-6 · Cited by 178 · see citing works
Self-citationMethotrexate Hepatotoxicity in Psoriasis—Comparison of Different Dose Regimens
Dahl, M. G. C., Gregory, M. M., & Scheuer, P. J. (1972) · BMJ · doi:10.1136/bmj.1.5801.654 · Cited by 177 · see citing works
Hug, H., Strand, S., Grambihler, A., Galle, J., Hack, V., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28191 · Cited by 177 · see citing works
Harrill, A. H., Watkins, P. B., Su, S., Ross, P. K., Harbourt, D. E., Stylianou, I. M., Boorman, G. A., Russo, M. W., Sackler, R. S., Harris, C., et al. (2009) · Genome Research · doi:10.1101/gr.090241.108 · Cited by 177 · see citing works
Poucell, S., Ireton, J., Valencia‐Mayoral, P., Downar, E., Larratt, L. M., Patterson, J., Blendis, L. M., & Phillips, M. J. (1984) · PubMed · Cited by 177 · see citing works
Clinical Syndromes and Consequences of Antiretroviral-Related Hepatotoxicity5, 1, 3
Núñez, M. (2010) · Hepatology · doi:10.1002/hep.23716 · Cited by 176 · see citing works
Watanabe, I., Tomita, A., Shimizu, M., Sugawara, M., Yasumo, H., Koishi, R., Takahashi, T., Miyoshi, K., Nakamura, K., Izumi, T., et al. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00014-6 · Cited by 174 · see citing works
Apostolova, N., Gómez-Sucerquia, L. J., Moran, A., Álvarez, Á., Blas‐García, A., & Esplugues, J. V. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00866.x · Cited by 173 · see citing works
Role of Fas Ligand in Apoptosis Induced by Hepatitis C Virus Infection
Mita, E., Hayashi, N., Iio, S., Takehara, T., Hijioka, T., Kasahara, A., Fusamoto, H., & Kamada, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2483 · Cited by 173 · see citing works
Iverson, S. L., & Uetrecht, J. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002029 · Cited by 173 · see citing works
Diabetes increases the risk of acute hepatic failure
El‐Serag, H. B., & Everhart, J. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.33650 · Cited by 173 · see citing works
Lewis, W., Copeland, W. C., & Day, B. J. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780288 · Cited by 173 · see citing works
[3] Glutathione biosynthesis and its inhibition
Meister, A. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)52005-8 · Cited by 171 · see citing works
Walker, U. A., Bäuerle, J., Laguno, M., Murillas, J., Mauss, S., Schmutz, G., Setzer, B., Miquel, R., Gatell, J. M., & Mallolas, J. (2004) · Hepatology · doi:10.1002/hep.20074 · Cited by 171 · see citing works
Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
Eliasson, E., & Kenna, J. G. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09316-2 · Cited by 170 · see citing works
Mallon, P. W. G., Unemori, P., Sedwell, R., Morey, A. L., Rafferty, M., Williams, K., Chisholm, D. J., Samaras, K., Emery, S., Kelleher, A. D., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429697 · Cited by 170 · see citing works
Shekhawat, P., Bennett, M. J., Sadovsky, Y., Nelson, D. M., Rakheja, D., & Strauss, A. W. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00481.2002 · Cited by 170 · see citing works
Lewis, W., Levine, E. S., Griniuvienė, B., Tankersley, K. O., Colacino, J. M., Sommadossi, J., Watanabe, K. A., & Perrino, F. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3592 · Cited by 169 · see citing works
Penzo, D., Petronilli, V., Angelin, A., Cusan, C., Colonna, R., Scorrano, L., Pagano, F. C., Prato, M., Lisa, F. D., & Bernardi, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310381200 · Cited by 166 · see citing works
Nadanaciva, S., Dykens, J. A., Bernal, A. J., Capaldi, R., & Will, Y. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.06.003 · Cited by 166 · see citing works
Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs
Maida, I. R., Núñez, M., Ríos, M. J., Martín‐Carbonero, L., Sotgiu, G., Toro, C., Rivas, P., Barreiro, P., Mura, M. S., Babudieri, S., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000221683.44940.62 · Cited by 165 · see citing works
Perhexiline Maleate-Induced Cirrhosis
Pessayre, D., Bichara, M., Feldmann, G., Degott, C., Potet, F., & Benhamou, J. (1979) · Gastroenterology · doi:10.1016/s0016-5085(79)80145-6 · Cited by 164 · see citing works
Self-citationDNA damage by peroxynitrite characterized with DNA repair enzymes
Epe, B. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.21.4105 · Cited by 163 · see citing works
Fromenty, B., Fisch, C., Berson, A., Lettéron, P., Larrey, D. G., & Pessayre, D. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22965-2 · Cited by 163 · see citing works
Self-citationAcute Fatty Liver of Pregnancy
Kaplan, M. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508083130606 · Cited by 163 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases
Mansouri, A., Gattolliat, C., & Asselah, T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.083 · Cited by 817 · see citing works
Self-citationMolecular pathways of nonalcoholic fatty liver disease development and progression
Bessone, F., Razori, M. V., & Roma, M. G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2947-0 · Cited by 625 · see citing works
The past and present of serum aminotransferases and the future of liver injury biomarkers
McGill, M. R. (2016) · EXCLI journal · doi:10.17179/excli2016-800 · Cited by 488 · see citing works
Mitochondrial alterations in fatty liver diseases
Fromenty, B., & Roden, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.09.020 · Cited by 430 · see citing works
Self-citationDrug-induced liver injury: Interactions between drug properties and host factors
Chen, M., Suzuki, A., Borlak, J. T., Andrade, R. J., & Lucena, M. I. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.016 · Cited by 404 · see citing works
High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell–Derived Organoids
Shinozawa, T., Kimura, M., Cai, Y., Saiki, N., Yoneyama, Y., Ouchi, R., Koike, H., Maezawa, M., Zhang, R.-R., Dunn, A., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.10.002 · Cited by 378 · see citing works
Idiosyncratic Adverse Drug Reactions: Current Concepts
Uetrecht, J., & Naisbitt, D. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007450 · Cited by 308 · see citing works
CSH guidelines for the diagnosis and treatment of drug-induced liver injury
Drug-induced Liver Injury (DILI) Study Group, Yu, Y., Chinese Society of Hepatology (CSH), Mao, Y., Chen, C.-W., Chen, J., Chen, J., Cong, W., Ding, Y., Duan, Z., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9793-2 · Cited by 303 · see citing works
Drug induced liver injury: an update
García‐Cortés, M., Robles‐Díaz, M., Stephens, C. M., Ortega‐Alonso, A., Lucena, M. I., & Andrade, R. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02885-1 · Cited by 302 · see citing works
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293 · see citing works
Role and Mechanisms of Mitophagy in Liver Diseases
Ma, X., McKeen, T., Zhang, J., & Ding, W. (2020) · Cells · doi:10.3390/cells9040837 · Cited by 279 · see citing works
Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives
Shah, R. R., Morganroth, J., & Shah, D. R. (2013) · Drug Safety · doi:10.1007/s40264-013-0048-4 · Cited by 252 · see citing works
Glutathione defense mechanism in liver injury: Insights from animal models
Chen, Y., Dong, H., Thompson, D. C., Shertzer, H. G., Nebert, D. W., & Vasiliou, V. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.008 · Cited by 250 · see citing works
Fisher, K. W., Vuppalanchi, R., & Saxena, R. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0214-ra · Cited by 212 · see citing works
Animal models of drug-induced liver injury
McGill, M. R., & Jaeschke, H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.037 · Cited by 202 · see citing works
Toxicology Strategies for Drug Discovery: Present and Future
Blomme, E. A. G., & Will, Y. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00407 · Cited by 196 · see citing works
A human liver organoid screening platform for DILI risk prediction
Zhang, C. J., Meyer, S. R., O’Meara, M. J., Huang, S., Capeling, M. M., Ferrer-Torres, D., Childs, C. J., Spence, J. R., Fontana, R. J., & Sexton, J. Z. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.019 · Cited by 199 · see citing works
Biomarkers of Hepatic Toxicity: An Overview
Thakur, S., Kumar, V., Das, R., Sharma, V., & Mehta, D. K. (2024) · Current Therapeutic Research · doi:10.1016/j.curtheres.2024.100737 · Cited by 184 · see citing works
Liu, Y., & Wang, W. (2016) · Animal Science Journal · doi:10.1111/asj.12550 · Cited by 165 · see citing works
Mitochondrial Roles and Cytoprotection in Chronic Liver Injury
Esposti, D. D., Hamelin, J., Bosselut, N., Saffroy, R., Sebagh, M., Pommier, A., Martel, C., & Lemoine, A. (2012) · Biochemistry Research International · doi:10.1155/2012/387626 · Cited by 159 · see citing works
Patel, V. A., & Sanyal, A. J. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.012 · Cited by 150 · see citing works
Heidari, R., Niknahad, H., Sadeghi, A., Mohammadi, H., Ghanbarinejad, V., Ommati, M. M., Hosseini, A. Z., Azarpira, N., Khodaei, F., Farshad, O., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.010 · Cited by 126 · see citing works
Song, B.-J., Akbar, M., Abdelmegeed, M. A., Byun, K., Lee, B., Yoon, S. K., & Hardwick, J. P. (2014) · Redox Biology · doi:10.1016/j.redox.2014.10.004 · Cited by 123 · see citing works
“Furthermore, these protein adducts can serve as a neo-antigen of hapten–carrier conjugate proteins to activate immune responses and to facilitate infiltration of neutrophils into the liver to promote inflammation [18–21,24,166–168].”
BackgroundInfluentialA high content screening assay to predict human drug-induced liver injury during drug discovery
Persson, M., Løye, A. F., Mow, T. J., & Hornberg, J. J. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.08.001 · Cited by 119 · see citing works
Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease
Lee, J., Park, J.-S., & Roh, Y. S. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01178-1 · Cited by 119 · see citing works
McGill, M. R., & Jaeschke, H. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.920823 · Cited by 119 · see citing works
Mitochondrial–Lysosomal Axis in Acetaminophen Hepatotoxicity
Moles, A., Torres, S., Baulies, A., García‐Ruiz, C., & Fernández-Checa, J. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00453 · Cited by 116 · see citing works
Antidepressants- and antipsychotics-induced hepatotoxicity
Todorović, N., Đorđević, J., Pejić, S., Đorđević, N. O., & Pajović, S. B. (2021) · Archives of Toxicology · doi:10.1007/s00204-020-02963-4 · Cited by 119 · see citing works
Mechanistic review of drug-induced steatohepatitis
Schumacher, J. D., & Guo, G. L. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.08.022 · Cited by 113 · see citing works
Hu, J., Ramshesh, V. K., McGill, M. R., Jaeschke, H., & Lemasters, J. J. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv319 · Cited by 110 · see citing works
Bessone, F., Dirchwolf, M., Rodil, M. A., Razori, M. V., & Roma, M. G. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14952 · Cited by 108 · see citing works
Kang, S. W. S., Haydar, G., Taniane, C., Farrell, G. C., Arias, I. M., Lippincott‐Schwartz, J., & Fu, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165638 · Cited by 100 · see citing works
Vinken, M., & Blaauboer, B. J. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.12.004 · Cited by 96 · see citing works
Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis
Sharma, S. K., Guillou, D. L., & Chen, J. Y. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00832-w · Cited by 97 · see citing works
Badenhorst, C. P. S., van der Sluis, R., Erasmus, E., & van Dijk, A. A. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.796929 · Cited by 88 · see citing works
The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity
Lauschke, V. M., & Ingelman‐Sundberg, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101714 · Cited by 90 · see citing works
Jnaneshwari, S., Hemshekhar, M., Santhosh, M. S., Sunitha, K., Thushara, R. M., Thirunavukkarasu, C., Kemparaju, K., & Girish, K. S. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12016 · Cited by 88 · see citing works
Gómez‐Lechón, M. J., Tolosa, L., & Donato, M. T. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3277 · Cited by 87 · see citing works
Syed, M., Skonberg, C., & Hansen, S. H. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.11.020 · Cited by 86 · see citing works
Calcium Signaling in Liver Injury and Regeneration
Oliva‐Vilarnau, N., Hankeová, S., Vorrink, S. U., Mkrtchian, S., Andersson, E. R., & Lauschke, V. M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00192 · Cited by 84 · see citing works
Utzeri, E., & Usai, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i22.3954 · Cited by 86 · see citing works
Busting the myth of methotrexate chronic hepatotoxicity
Martino, V. D., Weil, D., Verhoeven, F., Aubin, F., Avouac, J., Vuitton, L., Lioté, F., Thévenot, T., & Wendling, D. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00883-4 · Cited by 83 · see citing works
Otieno, M. A., Snoeys, J., Lam, W. W., Ghosh, A., Player, M. R., Pocai, A., Salter, R., Simic, D., Skaggs, H. S., Singh, B., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx040 · Cited by 82 · see citing works
Garrett, S., Whitaker, R., Beeson, C., & Schnellmann, R. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214700 · Cited by 70 · see citing works
Contamination of Aflatoxins Induces Severe Hepatotoxicity Through Multiple Mechanisms
Hua, Z., Liu, R., Chen, Y., Liu, G., Li, C., Song, Y., Cao, Z., Li, W., Lu, C. C., Lu, C. C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.605823 · Cited by 78 · see citing works
Wang, W., Xu, Z., Yu, C., & Xu, X. (2017) · Animal Science Journal · doi:10.1111/asj.12796 · Cited by 76 · see citing works
Mitochondrial depolarization after acute ethanol treatment drives mitophagy in living mice
Samuvel, D. J., Li, L., Krishnasamy, Y., Gooz, M. B., Takemoto, K., Woster, P. M., Lemasters, J. J., & Zhong, Z. (2022) · Autophagy · doi:10.1080/15548627.2022.2046457 · Cited by 74 · see citing works
Treatment of acetaminophen-induced liver injury with exogenous mitochondria in mice
Shi, X., Bai, H., Zhao, M., Li, X., Sun, X., Jiang, H., & Fu, A. (2018) · Translational research · doi:10.1016/j.trsl.2018.02.003 · Cited by 74 · see citing works
Drug‐Induced Liver Injury: Clinical Evidence of N‐Acetyl Cysteine Protective Effects
Ntamo, Y., Ziqubu, K., Chellan, N., Nkambule, B. B., Nyambuya, T. M., Mazibuko-Mbeje, S. E., Gabuza, K., Marcheggiani, F., Tiano, L., & Dludla, P. V. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3320325 · Cited by 73 · see citing works
Acute Ethanol Causes Hepatic Mitochondrial Depolarization in Mice: Role of Ethanol Metabolism
Zhong, Z., Ramshesh, V. K., Rehman, H., Liu, Q., Theruvath, T. P., Krishnasamy, Y., & Lemasters, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091308 · Cited by 73 · see citing works
Vrbanac, J., & Slauter, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803620-4.00003-7 · Cited by 69 · see citing works
Mitochondrial Mechanisms of Necroptosis in Liver Diseases
Xue, C., Gu, X., Li, G., Bao, Z., & Li, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010066 · Cited by 70 · see citing works
Gerges, S. H., Wahdan, S. A., Elsherbiny, D. A., & El‐Demerdash, E. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119220 · Cited by 72 · see citing works
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Segovia‐Zafra, A., Zeo-Sánchez, D. E. D., Gomez, C. L., Pérez-Valdés, Z., García‐Fuentes, E., Andrade, R. J., Lucena, M. I., & Paz, M. V. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.013 · Cited by 71 · see citing works
Teo, Y. L., Ho, H. K., & Chan, A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.983075 · Cited by 64 · see citing works
Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review
Sodeifian, F., Seyedalhosseini, Z., Kian, N., Eftekhari, M., Najary, S., Mirsaeidi, M. S., Farsi, Y., & Nasiri, M. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.731436 · Cited by 63 · see citing works
Proteomic Profiling of Mouse Liver following Acute Toxoplasma gondii Infection
He, J.-J., Ma, J., Elsheikha, H. M., Song, H., Zhou, D., & Zhu, X.-Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152022 · Cited by 63 · see citing works
Silva, J., Spatz, M. H., Folk, C., Chang, A., Cadenas, E., Liang, J., & Davies, D. L. (2020) · Alcohol · doi:10.1016/j.alcohol.2020.10.002 · Cited by 62 · see citing works
Challenges and Future of Drug-Induced Liver Injury Research—Laboratory Tests
Weber, S., & Gerbes, A. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116049 · Cited by 64 · see citing works
Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™
Suzuki, A., Yuen, N., Ilić, K., Miller, R. T., Reese, M. J., Brown, H. R., Ambroso, J. L., Falls, J. G., & Hunt, C. M. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.05.004 · Cited by 61 · see citing works
Mitochondrial Mechanisms of Apoptosis and Necroptosis in Liver Diseases
Chu, Q., Gu, X., Zheng, Q., Wang, J., & Zhu, H. (2021) · Analytical Cellular Pathology · doi:10.1155/2021/8900122 · Cited by 62 · see citing works
Long Term Influence of Carbon Nanoparticles on Health and Liver Status in Rats
Strojny, B., Kurantowicz, N., Sawosz, E., Grodzik, M., Jaworski, S., Kutwin, M., Wierzbicki, M., Hotowy, A., Lipińska, L., & Chwalibóg, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144821 · Cited by 60 · see citing works
Hunt, C. M., Yuen, N., Stirnadel-Farrant, H. A., & Suzuki, A. (2014) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2014.09.007 · Cited by 59 · see citing works
Szalowska, E., van der Burg, B., Man, H.-Y., Hendriksen, P. J. M., & Peijnenburg, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086795 · Cited by 59 · see citing works
Weng, Z., Luo, Y., Yang, X., Greenhaw, J. J., Li, H., Xie, L., Mattes, W. B., & Shi, Q. (2014) · Toxicology · doi:10.1016/j.tox.2014.11.002 · Cited by 58 · see citing works
Lee, K. K., & Boelsterli, U. A. (2014) · Redox Biology · doi:10.1016/j.redox.2014.03.003 · Cited by 57 · see citing works
High-content screening technology for studying drug-induced hepatotoxicity in cell models
Tolosa, L., Gómez‐Lechón, M. J., & Donato, M. T. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1503-z · Cited by 56 · see citing works
Zhong, Z., & Lemasters, J. J. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13877 · Cited by 55 · see citing works
Drug-Induced Inhibition of Mitochondrial Fatty Acid Oxidation and Steatosis
Massart, J., Begriche, K., Buron, N., Porceddu, M., Borgne‐Sanchez, A., & Fromenty, B. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0022-y · Cited by 54 · see citing works
Self-citationMechanisms of drug induced liver injury
Skat‐Rørdam, J., Lykkesfeldt, J., Gluud, L. L., & Tveden‐Nyborg, P. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05744-3 · Cited by 53 · see citing works
Zhang, T., Ikejima, T., Li, L., Wu, R., Yuan, X., Zhao, J., Wang, Y., & Peng, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00753 · Cited by 53 · see citing works
Mitochondrial dysfunction induced by leflunomide and its active metabolite
Xuan, J., Ren, Z., Qing, T., Couch, L. H., Shi, L. M., Tolleson, W. H., & Guo, L. (2018) · Toxicology · doi:10.1016/j.tox.2018.02.003 · Cited by 53 · see citing works
Development of a neurotoxicity assay that is tuned to detect mitochondrial toxicants
Delp, J., Funke, M., Rudolf, F., Cediel-Ulloa, A., Bennekou, S. H., van der Stel, W., Carta, G., Jennings, P., Toma, C., Gardner, I. B., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02473-y · Cited by 53 · see citing works
Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure
Liu, A., Walter, M., Wright, P. S. R., Bartosik, A., Dolciami, D., Elbasir, A., Yang, H., & Bender, A. (2021) · Biology Direct · doi:10.1186/s13062-020-00285-0 · Cited by 53 · see citing works
High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins
Tolosa, L., Carmona, A. L., Castell, J. V., Gómez‐Lechón, M. J., & Donato, M. T. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1334-3 · Cited by 52 · see citing works
In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach
Tabernilla, A., Rodrigues, B. D. S., Pieters, A., Caufriez, A., Leroy, K., Campenhout, R. V., Cooreman, A., Gomes, A. R., Arnesdotter, E., Gijbels, E., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095038 · Cited by 54 · see citing works
Jang, S., Yu, L., Abdelmegeed, M. A., Gao, Y., Banerjee, A., & Song, B. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.040 · Cited by 50 · see citing works
He, J.-J., Ma, J., Elsheikha, H. M., Song, H., Huang, S., & Zhu, X.-Q. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1716-x · Cited by 50 · see citing works
Song, B., Akbar, M. D., Jo, I., Hardwick, J. P., & Abdelmegeed, M. A. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.04.002 · Cited by 49 · see citing works
Zhang, F., Chen, L., Jin, H., Shao, J., Wu, L., Lu, Y., & Zheng, S. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.11.005 · Cited by 49 · see citing works
Jiang, H., Gao, H., Li, J., Zhou, T., Wang, S., Yang, J.-B., Hao, R., Pang, F., Wei, F., Liu, Z., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115630 · Cited by 48 · see citing works
Induced volatolomics of pathologies
Djago, F., Lange, J., & Poinot, P. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-020-00248-z · Cited by 47 · see citing works
Dynamic carbon 13 breath tests for the study of liver function and gastric emptying
Bonfrate, L., Grattagliano, I., Palasciano, G., & Portincasa, P. (2014) · Gastroenterology report · doi:10.1093/gastro/gou068 · Cited by 47 · see citing works
Ferron, P., Gicquel, T., Mégarbane, B., Clément, B., & Fromenty, B. (2020) · Biochimie · doi:10.1016/j.biochi.2020.08.018 · Cited by 46 · see citing works
Self-citationFan, Q., Zhao, B., Wang, C., Zhang, J., Wu, J., Wang, T., & Xu, A. (2018) · Molecules · doi:10.3390/molecules23102486 · Cited by 43 · see citing works
Pradip, A., Steel, D. M., Jacobsson, S., Holmgren, G., Ingelman‐Sundberg, M., Sartipy, P., Björquist, P., Johansson, I., & Edsbagge, J. (2016) · Stem Cells International · doi:10.1155/2016/2475631 · Cited by 42 · see citing works
Weaver, R. J., Betts, C. J., Blomme, E. A. G., Gerets, H. H. J., Jensen, K. G., Hewitt, P. G., Juhila, S., Labbe, G., Liguori, M. J., Mesens, N., et al. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1341489 · Cited by 41 · see citing works
Wan, X., Li, N., Chen, Y. J., Chen, X. S., Yang, Z., Xu, L., Yang, H., & Wang, Z. (2021) · Poultry Science · doi:10.1016/j.psj.2021.101441 · Cited by 42 · see citing works
Mitochondrial Dysfunction and Acute Fatty Liver of Pregnancy
Ramanathan, R., & Ibdah, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073595 · Cited by 42 · see citing works
Qu, D., Gu, Y., Feng, L., & Han, J. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.04.102 · Cited by 41 · see citing works
Hepatotoxicity due to herbal dietary supplements: Past, present and the future
Gurley, B. J., McGill, M. R., & Koturbash, I. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113445 · Cited by 42 · see citing works
Park, M. N., Rahman, M. A., Rahman, M. H., Kim, J. W., Choi, M. J., Kim, J. W., Choi, J., Moon, M., Ahmed, K. R., & Kim, B. (2022) · Antioxidants · doi:10.3390/antiox11102041 · Cited by 43 · see citing works
Bavachinin Induces Oxidative Damage in HepaRG Cells through p38/JNK MAPK Pathways
Wang, S., Wang, M., Wang, M., Tian, Y., Sun, X. Y., Sun, G., & Sun, X. (2018) · Toxins · doi:10.3390/toxins10040154 · Cited by 40 · see citing works
Wewering, F., Jouy, F., Wissenbach, D. K., Gebauer, S., Blüher, M., Gebhardt, R., Pirow, R., von Bergen�, M., Kalkhof, S., Luch, A., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1686-y · Cited by 39 · see citing works
High-Content Screening for the Detection of Drug-Induced Oxidative Stress in Liver Cells
Donato, M. T., & Tolosa, L. (2021) · Antioxidants · doi:10.3390/antiox10010106 · Cited by 40 · see citing works
Imaizumi, N., Lee, K. K., Zhang, C., & Boelsterli, U. A. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.005 · Cited by 38 · see citing works
Roberts, E. A. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139012102.023 · Cited by 37 · see citing works
SARS-CoV-2 related liver impairment – perception may not be the reality
Philips, C. A., Ahamed, R., & Augustine, P. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.025 · Cited by 36 · see citing works
Takai, S., Oda, S., Tsuneyama, K., Fukami, T., Nakajima, M., & Yokoi, T. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3141 · Cited by 35 · see citing works
Mitochondria in Acetaminophen-Induced Liver Injury and Recovery: A Concise Review
Ramachandran, A., & Jaeschke, H. (2023) · Livers · doi:10.3390/livers3020014 · Cited by 34 · see citing works
- Authors
- Pessayre, D., Fromenty, B., Berson, A., Robin, M.-A., Lettéron, P., Moreau, R., & Mansouri, A.
- Affiliations
- Inserm (FR)
- Corresponding author
- Pessayre, Dominique
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2012-01-30
- Volume
- 44
- Issue
- 1
- Pages
- 34-87
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2076781542
- Cited by
- 277
- References
- 604
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 11 · 2023: 21 · 2022: 22 · 2021: 31 · 2020: 16 · 2019: 15 · 2018: 26 · 2017: 19 · 2016: 21 · 2015: 26 · 2014: 23 · 2013: 13 · 2012: 2
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Metabolism Reviews (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- drug-induced liver injury, mitochondrial dysfunction, reactive drug metabolites, mitochondrial membrane disruption, oxidative phosphorylation, ATP synthase inhibition, mitochondrial DNA damage, lactic acidosis, hepatic steatosis, steatosis, lipid peroxidation, human leukocyte antigen, genetic susceptibility, drug safety testing
- MeSH terms
- DNA, Mitochondrial, Pharmaceutical Preparations, Fatty Liver, Humans, Immune System, Liver, Mitochondria, Liver, Oxidation-Reduction, Reactive Oxygen Species, Cell Respiration, Mitochondrial Proteins, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review